federal_register: 2024-28229
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-28229 | Food and Drug Administration's Best Practices for Food and Drug Administration Communication With Interested Parties: Draft Report for Public Comment; Availability | Notice | The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft document entitled "Best Practices for FDA Communication with Interested Parties: Draft Report for Public Comment." This draft report and implementation plan respond to the Consolidated Appropriations Act of 2023, which directs FDA to issue a report on FDA's practices for broadly communicating with external interested parties and a plan for implementation of such best practices. In addition, FDA is to conduct a review of the types and methods of public communication that FDA uses to communicate and interact with medical product sponsors and other external interested parties; identify best practices for the efficient development, issuance, and use of such communications; and develop a plan for implementation of best practices for these communications. As directed, FDA is publishing and soliciting feedback on this draft report and implementation plan. | 2024-12-03 | 2024 | 12 | https://www.federalregister.gov/documents/2024/12/03/2024-28229/food-and-drug-administrations-best-practices-for-food-and-drug-administration-communication-with | https://www.govinfo.gov/content/pkg/FR-2024-12-03/pdf/2024-28229.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft document entitled "Best Practices for FDA Communication with Interested Parties: Draft Report for Public Comment." This draft report and implementation plan... |